Skip to content

Corteva Agriscience Belgium

Active Risk: moderate Private limited companyfounded 2016active for 9 yearsMontoyerstraat 25, 1000 BrusselsKBO/BCE: BE 0665.877.284 subsidiary of DowDuPont Inc.

Board

3 directors, 1 auditor, last change in October 2026
Director
appointed by deed of 27-10-2026 term without a fixed end
Director
appointed by deed of 27-10-2026 term without a fixed end
Director
in office according to the deed of 24-02-2021 term without a fixed end
Statutory auditor, permanent representative Kevin Veestraeten
appointed by deed of 06-07-2020
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 27-10-2026

Office holders in the KBO →

Mandates through the years

8 names, the dashed line is today
Filip Cnudde
Director
BoardEarliermandate already running before its first mention
Mandates as a list
  • Herlinde Noppe
    • Director, since before 24-02-2021
  • Alessio Ghiani
    • Director, appointed by deed of 27-10-2026, still in office
  • Willem (Wim) Boudeling
    • Director, appointed by deed of 27-10-2026, still in office
  • PricewaterhouseCoopers Reviseurs d'Entreprises
    • Statutory auditor, appointed by deed of 06-07-2020, still in office
  • Filip Cnudde
    • Director, from before 24-02-2021 to 01-10-2026
  • Teresa Babuscio
    • Director, appointed by deed of 18-01-2024, until 01-10-2026
  • Herlinde Noppе
    • Director, until 31-12-2023
  • George Merriman
    • Director, from before 24-02-2021 to 23-12-2022

Control

Consolidating parent
DowDuPont Inc. US
consolidates
This company
Corteva Agriscience Belgium
Equity €20.0m
Profit €1.2m in 2023

Capital

Contribution
€17,290,841
Shares
429,042
Contribution per share
€40.30
Equity per share
€46.54 in 2023
Source
2023 annual accounts

Owners through the years

as the annual accounts name them
DowDuPont Inc. US
consolidates
Owners as a list

Source: parent in its own accounts

Articles of association

deed of 24-02-2021 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited

Capital transactions

Capital over time
  1. 13-10-2022 Capital increase of €16,276,173 · 429,042 new shares · in kind
  2. 24-02-2021 Converted to unavailable equity
  3. 24-02-2021 Converted to available equity

Next steps